2.70
Schlusskurs vom Vortag:
$2.87
Offen:
$2.74
24-Stunden-Volumen:
39,684
Relative Volume:
0.77
Marktkapitalisierung:
$120.67M
Einnahmen:
$11.51M
Nettoeinkommen (Verlust:
$-101.84M
KGV:
-1.0107
EPS:
-2.6714
Netto-Cashflow:
$-82.98M
1W Leistung:
-3.91%
1M Leistung:
-9.40%
6M Leistung:
-42.18%
1J Leistung:
-65.12%
Nyxoah Sa Stock (NYXH) Company Profile
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NYXH
Nyxoah Sa
|
2.70 | 128.27M | 11.51M | -101.84M | -82.98M | -2.6714 |
|
ISRG
Intuitive Surgical Inc
|
436.64 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.70 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
207.98 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
Nyxoah Q1 earnings call highlights - MSN
Nyxoah Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Continued ProgressFinal Results - Newser
Nyxoah SA (NYXH) Stock Analysis: Flat at $2.90, What's Next 2026-05-21Linear Regression - Newser
Nyxoah SA (NYXH) Delivers Q1 2026 Beat — EPS $-0.37 vs $-0.51 ExpectedTrending Volume Leaders - Newser
Nyxoah details 44.7m voting shares, up to 8.6m via bonds - Stock Titan
Nyxoah Welcomes the Flemish Investors Federation (VFB) at - GlobeNewswire
Nyxoah SA Earnings Call Highlights Growth And Strain - TipRanks
Nyxoah SA (NYXH) Fell -3.92% — Is a Recovery Ahead? 2026-05-19Bear Flag - Newser
Nyxoah SA (NYXH) Stock: Slides -4.10%, Support at $2.67 2026-05-19Trending Momentum Stocks - Newser
Analysts Are Upgrading Nyxoah SA (EBR:NYXH) After Its Latest Results - simplywall.st
Nyxoah SAOrdinary Shares (NQ: NYXH - FinancialContent
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips - Investing.com Nigeria
Transcript : Nyxoah SA Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 05 - marketscreener.com
NYXH: Rapid U.S. commercialization and strong clinical results drive growth in sleep apnea neuromodulation - TradingView
Nyxoah Earnings Call: Growth Surges Amid Cash Strain - TipRanks
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns - Investing.com UK
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns By Investing.com - Investing.com India
This Toast Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Sahm
Nyxoah SA Stock 12‑Month Price Target Cut to $9.16, Implies 198% Upside - TradingView
Nyxoah S.A. (NASDAQ:NYXH) Q1 2026 Earnings Call Transcript - Insider Monkey
Nyxoah SA Stock 12‑Month Price Target Cut to $9.19, Implies 199% Upside - TradingView
Earnings Call Summary | Nyxoah SA(NYXH.US) Q1 2026 Earnings Conference - Moomoo
Nyxoah Q1 Earnings Call Highlights - sharewise.com
Nyxoah SA (NYXH) reports Q1 loss, tops revenue estimates - MSN
Nyxoah SA reports results for the quarter ended March 31Earnings Summary - TradingView
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips By Investing.com - Investing.com South Africa
Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Nyxoah Calls June 10 Shareholder Meetings and Files Q1 2026 Results - TipRanks
Nyxoah Reports First Quarter 2026 Financial and Operating Results - The Manila Times
NYXH: Q1 2026 net revenue rose to €6.4M, driven by U.S. Genio launch and robust reimbursement - TradingView
Nyxoah (Nasdaq: NYXH) posts Q1 2026 surge in revenue but flags funding risk - Stock Titan
Nyxoah : Q1 Report 2026 - marketscreener.com
Stifel cuts Nyxoah stock rating on reimbursement challenges By Investing.com - Investing.com Australia
Stifel cuts Nyxoah stock rating on reimbursement challenges - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Nyxoah to let registered holders follow June 10 meetings by video - Stock Titan
Invitation to attend the annual and the extraordinary - GlobeNewswire
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
Earnings Preview: Nyxoah SA to Report Financial Results on May 12 - 富途牛牛
What makes Nyxoah SA (NYXH) a safer bet than newer entrants (-0.62%) 2026-05-07Investment Picks - Newser
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets - Yahoo Finance
Nyxoah (NYXH) Earnings Date and Reports 2026 - MarketBeat
Nyxoah : to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Latest NYXH NewsNyxoah Announces Pricing of Nasdaq Public O... - Stock Titan
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference - The Manila Times
Nyxoah (NYXH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Nyxoah (NYXH) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - Sahm
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):